查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1819868

2025-2033年抗凝血剂市场报告（依药物类别、给药途径、配销通路、应用及地区）

Anticoagulants Market Report by Drug Class, Route of Administration, Distribution Channel, Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球抗凝血剂市场规模达449亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到968亿美元，2025-2033年期间的复合年增长率（CAGR）为8.46%。血栓性疾病病例的增加、久坐不动的生活方式以及医疗保健产业的改善是推动市场发展的一些关键因素。

抗凝血剂是一种预防血栓形成并降低中风、心臟病等严重疾病风险的药物。它们有助于治疗阻碍血液在血管中流动的现有血栓，防止其扩大，并降低严重併发症的风险。抗凝血剂有不同强度和颜色，有口服剂型（例如片剂和胶囊）和注射剂型。目前，直接口服抗凝血剂 (DOAc) 因其使用方便且无需常规监测，正日益成为处方药。

抗凝血剂市场趋势：

全球范围内老年人口的增长以及人类免疫缺陷病毒 (HIV)、莱姆病、肥胖症、丙型肝炎、慢性发炎和心血管疾病的日益流行是影响全球市场的关键因素之一。此外，由于久坐的生活方式和繁忙的工作日程，肺栓塞 (PE) 等血栓性疾病病例不断增加，导致全球心臟相关疾病增加。久坐、吸烟、创伤、血液疾病和自体免疫疾病会增加身体不同部位血液凝结的风险，从而刺激对抗凝剂的需求。除此之外，药物发现研发 (R&D) 活动的不断进步以及人工智慧 (AI) 和机器学习 (ML) 等先进技术的整合，用于分析大量资料、识别潜在候选药物和开发新药，正在推动市场成长。与此相符的是，医疗保健提供者正致力于根据患者的基因和临床资料，为其提供个人化的抗凝血治疗。人工智慧有助于确定最有效的抗凝血剂剂量和类型，从而降低併发症风险并改善治疗效果。此外，非营利组织为提高心血管健康意识而采取的积极倡议，以及各国政府与公共卫生机构在预防心臟病和中风方面日益加强的合作，正在推动全球市场的成长。医疗保健行业的蓬勃发展以及药品价格和可及性的提高等其他因素也刺激了市场的成长。

本报告回答的关键问题

  • 2024年全球抗凝血剂市场规模？ 2025-2033年全球抗凝血剂市场的预期成长率是多少？
  • 推动全球抗凝血剂市场发展的关键因素有哪些？
  • COVID-19 对全球抗凝血剂市场有何影响？
  • 根据药物类别，全球抗凝血剂市场是如何分類的？
  • 根据给药途径，全球抗凝血剂市场如何分布？
  • 根据配销通路，全球抗凝血剂市场如何分布？
  • 根据应用，全球抗凝血剂市场是如何分布的？
  • 全球抗凝血剂市场的主要区域有哪些？
  • 全球抗凝血剂市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球抗凝血剂市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依药品类别

  • 新型口服抗凝血药物（NOAC）
  • 肝素和低分子量肝素（LMWH）
  • 维生素K拮抗剂
  • 其他的

第七章：市场区隔：依行政途径

  • 口服抗凝血剂
  • 注射用抗凝血剂

第八章：市场区隔：按配销通路

  • 医院药房
  • 零售药局
  • 网上商店
  • 其他的

第九章：市场区隔：依应用

  • 心房颤动和心臟病发作
  • 中风
  • 深部静脉血栓（DVT）
  • 肺栓塞（PE）
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 11 章：SWOT 分析

第 12 章：价值链分析

第 13 章：波特五力分析

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Alexion Pharmaceuticals Inc
    • Aspen Holdings
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • Daiichi Sankyo Company Limited
    • Dr. Reddy's Laboratories Ltd
    • GlaxoSmithKline plc
    • Johnson & Johnson Private Limited
    • Pfizer Inc.
    • Sanofi
Product Code: SR112025A4360

The global anticoagulants market size reached USD 44.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 96.8 Billion by 2033, exhibiting a growth rate (CAGR) of 8.46% during 2025-2033. The rising cases of thrombotic disorders, sedentary lifestyles, and the improving healthcare sector represent some of the key factors driving the market.

Anticoagulants are medicines that prevent the formation of blood clots and reduce the chances of developing severe conditions, such as strokes and heart attacks. They assist in treating existing blood clots that resist the flow of blood through vessels and prevent them from getting larger and reducing the risk of serious complications. They are available in different strengths and colors and as oral, such as tablets and capsules, and injectable variants. At present, direct oral anticoagulants (DOAc) are increasingly being prescribed on account of their ease of use and lack of need for routine monitoring.

Anticoagulants Market Trends:

The growing geriatric population and increasing prevalence of human immunodeficiency virus (HIV), lyme disease, obesity, hepatitis C, chronic inflammation, and cardiovascular disorders across the globe represent one of the key factors positively influencing the market across the globe. In addition, rising cases of thrombotic disorders, such as pulmonary embolism (PE), on account of sedentary lifestyles and hectic work schedules are inducing the growth of heart-related diseases worldwide. Moreover, extended sitting, smoking, trauma, blood disorders, and autoimmune diseases are increasing the risk of blood clotting in different parts of the body, which, in turn, is catalyzing the demand for anticoagulants. Apart from this, increasing advancements in research and development (R&D) activities in drug discovery and the integration of advanced technologies, such as artificial intelligence (AI) and machine learning (ML) to analyze large amounts of data, identify potential drug candidates and develop a new drug is fueling the market growth. In line with this, healthcare providers are focusing on personalizing anticoagulant therapy for individual patients based on their genetic and clinical data. AI assists in identifying the most effective dose and type of anticoagulant for the patient, which, in turn, reduces the risk of complications and improves outcomes. Furthermore, favorable initiatives by non-profitable organizations to promote awareness about cardiovascular health and the growing partnerships between governments of various countries and public health agencies to prevent heart disease and strokes are propelling the growth of the market worldwide. Other factors like the burgeoning healthcare sector and increasing affordability and accessibility of drugs are stimulating the growth of the market.

Key Market Segmentation:

Drug Class Insights:

  • Novel Oral Anticoagulants (NOACs)
  • Heparin and Low Molecular Weight Heparin (LMWH)
  • Vitamin K Antagonist
  • Others

Route of Administration Insights:

  • Oral Anticoagulant
  • Injectable Anticoagulant

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores
  • Others

Application Insights:

  • Atrial Fibrillation and Heart Attack
  • Stroke
  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Others

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for anticoagulants. Some of the factors driving the North America anticoagulants market included the increasing prevalence of thrombotic disorders, developed healthcare sector, ongoing research and development (R&D) activities in drug discovery etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global anticoagulants market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Alexion Pharmaceuticals Inc, Aspen Holdings, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Dr. Reddy's Laboratories Ltd, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Pfizer Inc., Sanofi, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report

Key Questions Answered in This Report

  • 1.What was the size of the global anticoagulants market in 2024?
  • 2.What is the expected growth rate of the global anticoagulants market during 2025-2033?
  • 3.What are the key factors driving the global anticoagulants market?
  • 4.What has been the impact of COVID-19 on the global anticoagulants market?
  • 5.What is the breakup of the global anticoagulants market based on the drug class?
  • 6.What is the breakup of the global anticoagulants market based on the route of administration?
  • 7.What is the breakup of the global anticoagulants market based on the distribution channel?
  • 8.What is the breakup of the global anticoagulants market based on the application?
  • 9.What are the key regions in the global anticoagulants market?
  • 10.Who are the key players/companies in the global anticoagulants market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Anticoagulants Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Novel Oral Anticoagulants (NOACs)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Heparin and Low Molecular Weight Heparin (LMWH)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Vitamin K Antagonist
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral Anticoagulant
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Injectable Anticoagulant
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Atrial Fibrillation and Heart Attack
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Stroke
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Deep Vein Thrombosis (DVT)
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Pulmonary Embolism (PE)
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Alexion Pharmaceuticals Inc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Aspen Holdings
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Boehringer Ingelheim International GmbH
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Bristol-Myers Squibb Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Daiichi Sankyo Company Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Dr. Reddy's Laboratories Ltd
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 GlaxoSmithKline plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Johnson & Johnson Private Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sanofi
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Anticoagulants Market: Major Drivers and Challenges
  • Figure 2: Global: Anticoagulants Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Anticoagulants Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Anticoagulants Market: Breakup by Drug Class (in %), 2024
  • Figure 5: Global: Anticoagulants Market: Breakup by Route of Administration (in %), 2024
  • Figure 6: Global: Anticoagulants Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Anticoagulants Market: Breakup by Application (in %), 2024
  • Figure 8: Global: Anticoagulants Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Anticoagulants (Vitamin K Antagonist) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Anticoagulants (Vitamin K Antagonist) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Anticoagulants (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Anticoagulants (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Anticoagulants (Oral Anticoagulant) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Anticoagulants (Oral Anticoagulant) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Anticoagulants (Injectable Anticoagulant) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Anticoagulants (Injectable Anticoagulant) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Anticoagulants (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Anticoagulants (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Anticoagulants (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Anticoagulants (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Anticoagulants (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Anticoagulants (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Anticoagulants (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Anticoagulants (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Anticoagulants (Stroke) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Anticoagulants (Stroke) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Anticoagulants (Pulmonary Embolism-PE) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Anticoagulants (Pulmonary Embolism-PE) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Anticoagulants (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Anticoagulants (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: North America: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: North America: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: United States: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: United States: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Canada: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Canada: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Asia-Pacific: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Asia-Pacific: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: China: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: China: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Japan: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Japan: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: India: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: India: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: South Korea: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: South Korea: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Australia: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Australia: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Indonesia: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Indonesia: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Europe: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Europe: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Germany: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Germany: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: France: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: France: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: United Kingdom: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: United Kingdom: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Italy: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Italy: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Spain: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Spain: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Russia: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Russia: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Latin America: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Latin America: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Brazil: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Brazil: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Mexico: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Mexico: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Others: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Others: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Middle East and Africa: Anticoagulants Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Middle East and Africa: Anticoagulants Market: Breakup by Country (in %), 2024
  • Figure 87: Middle East and Africa: Anticoagulants Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Global: Anticoagulants Industry: SWOT Analysis
  • Figure 89: Global: Anticoagulants Industry: Value Chain Analysis
  • Figure 90: Global: Anticoagulants Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Anticoagulants Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Anticoagulants Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 3: Global: Anticoagulants Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 4: Global: Anticoagulants Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Anticoagulants Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 6: Global: Anticoagulants Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Anticoagulants Market: Competitive Structure
  • Table 8: Global: Anticoagulants Market: Key Players